Disney's dive after earnings could open up a buying opportunity to investors that missed the recent run.
The food giant is one of the few stocks holding its ground on Monday morning; here's why.
Following growing scandal, CannTrust Holdings is luring bargain shoppers as the stock moves higher after the company announced it's considering selling itself.
Apple has investors and analysts looking forward to its the 5G future.
The merger with Pfizer's off-patent branded medicines business may be a life-preserver for bulls and provide meaningful expansion across geographical regions while leveraging Pfizer's commercialization capabilities.
But this off-patent tie-up comes with some questions -- such as why are so many Mylan executives hanging on?
What new management means for Mylan shareholders moving forward.
Pfizer will combine its off-patent drug business with Mylan in the as-yet-to-be-named new company.
Also, defense industry names can breathe easier with word of debt ceiling and federal spending deal.
The issue is whether it will inspire longer-term customer relationships.